tiprankstipranks
Trending News
More News >
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
US Market

Kezar Life Sciences (KZR) Ratios

Compare
473 Followers

Kezar Life Sciences Ratios

KZR's free cash flow for Q3 2025 was $―. For the 2025 fiscal year, KZR's free cash flow was decreased by $ and operating cash flow was $―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
7.29 6.76 11.66 25.98 25.77
Quick Ratio
7.29 6.76 11.66 25.98 25.47
Cash Ratio
2.39 2.05 2.00 3.68 7.66
Solvency Ratio
-4.04 -2.98 -2.99 -2.17 -2.46
Operating Cash Flow Ratio
-4.48 -3.65 -4.60 -5.35 -5.17
Short-Term Operating Cash Flow Coverage
-7.07 -14.23 0.00 -22.94 -35.39
Net Current Asset Value
$ 87.36M$ 109.72M$ 173.28M$ 256.03M$ 190.60M
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.11 0.09 0.07 0.06
Debt-to-Equity Ratio
0.10 0.14 0.10 0.08 0.07
Debt-to-Capital Ratio
0.09 0.12 0.09 0.07 0.07
Long-Term Debt-to-Capital Ratio
<0.01 0.04 0.05 0.04 0.05
Financial Leverage Ratio
1.19 1.24 1.18 1.11 1.11
Debt Service Coverage Ratio
-6.62 -11.91 -64.03 -16.85 -38.00
Interest Coverage Ratio
-52.56 -56.88 -67.89 -60.05 -343.77
Debt to Market Cap
0.21 0.02 <0.01 <0.01 <0.01
Interest Debt Per Share
1.49 0.24 0.28 0.33 0.27
Net Debt to EBITDA
0.36 0.32 0.17 0.29 0.92
Profitability Margins
Gross Profit Margin
0.00%0.00%100.00%0.00%0.00%
EBIT Margin
0.00%0.00%-1433.14%0.00%0.00%
EBITDA Margin
0.00%0.00%-1417.91%0.00%0.00%
Operating Profit Margin
0.00%0.00%-1503.39%0.00%0.00%
Pretax Profit Margin
0.00%0.00%-1455.29%0.00%0.00%
Net Profit Margin
0.00%0.00%-1455.29%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%-1455.29%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%95.72%97.53%
EBT Per EBIT
93.47%92.42%96.80%95.89%99.95%
Return on Assets (ROA)
-64.87%-57.88%-46.05%-21.80%-24.45%
Return on Equity (ROE)
-63.52%-71.62%-54.31%-24.20%-27.06%
Return on Capital Employed (ROCE)
-79.93%-72.86%-51.72%-24.66%-26.06%
Return on Invested Capital (ROIC)
-72.92%-68.07%-50.96%-23.19%-25.13%
Return on Tangible Assets
-64.87%-57.88%-46.05%-21.80%-24.45%
Earnings Yield
-155.67%-17.09%-1.48%-0.14%-0.06%
Efficiency Ratios
Receivables Turnover
0.00 0.00 3.06 0.00 0.00
Payables Turnover
0.44 0.28 0.00 0.41 0.74
Inventory Turnover
0.00 0.00 0.00 0.00 0.60
Fixed Asset Turnover
0.00 0.00 0.81 0.00 0.00
Asset Turnover
0.00 0.00 0.03 0.00 0.00
Working Capital Turnover Ratio
0.00 0.00 0.03 0.00 0.00
Cash Conversion Cycle
-826.43 -1.28K 119.46 -884.49 114.09
Days of Sales Outstanding
0.00 0.00 119.46 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 604.30
Days of Payables Outstanding
826.43 1.28K 0.00 884.49 490.21
Operating Cycle
0.00 0.00 119.46 0.00 604.30
Cash Flow Ratios
Operating Cash Flow Per Share
-8.80 -1.02 -1.13 -0.87 -0.80
Free Cash Flow Per Share
-8.80 -1.02 -1.15 -0.90 -0.81
CapEx Per Share
<0.01 <0.01 0.02 0.02 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.02 1.03 1.01
Dividend Paid and CapEx Coverage Ratio
-1.74K -2.56K -45.11 -37.29 -134.29
Capital Expenditure Coverage Ratio
-1.74K -2.56K -45.11 -37.29 -134.29
Operating Cash Flow Coverage Ratio
-6.81 -4.59 -4.31 -2.77 -3.02
Operating Cash Flow to Sales Ratio
0.00 0.00 -11.66 0.00 0.00
Free Cash Flow Yield
-141.25%-15.15%-1.21%-0.13%-0.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.64 -5.85 -67.45 -726.13 -1.66K
Price-to-Sales (P/S) Ratio
0.00 0.00 981.55 0.00 0.00
Price-to-Book (P/B) Ratio
0.50 4.19 36.63 175.74 448.07
Price-to-Free Cash Flow (P/FCF) Ratio
-0.71 -6.60 -82.33 -784.92 -2.06K
Price-to-Operating Cash Flow Ratio
-0.71 -6.60 -84.15 -805.96 -2.08K
Price-to-Earnings Growth (PEG) Ratio
0.02 0.33 -1.52 183.35 -122.80
Price-to-Fair Value
0.50 4.19 36.63 175.74 448.07
Enterprise Value Multiple
-0.30 -5.73 -69.06 -717.12 -1.66K
Enterprise Value
20.63M 464.34M 6.85B 47.41B 88.16B
EV to EBITDA
-0.30 -5.73 -69.06 -717.12 -1.66K
EV to Sales
0.00 0.00 979.18 0.00 0.00
EV to Free Cash Flow
-0.32 -6.25 -82.13 -784.60 -2.06K
EV to Operating Cash Flow
-0.32 -6.26 -83.95 -805.64 -2.08K
Tangible Book Value Per Share
12.55 1.60 2.59 4.01 3.73
Shareholders’ Equity Per Share
12.55 1.60 2.59 4.01 3.73
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.04 0.02
Revenue Per Share
0.00 0.00 0.10 0.00 0.00
Net Income Per Share
-9.68 -1.15 -1.40 -0.97 -1.01
Tax Burden
1.00 1.00 1.00 0.96 0.98
Interest Burden
1.02 1.02 1.02 1.02 1.00
Research & Development to Revenue
0.00 0.00 12.24 0.00 0.00
SG&A to Revenue
0.00 0.00 3.79 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 2.59 0.00 0.00
Income Quality
0.91 0.89 0.80 0.86 0.78
Currency in USD